94 related articles for article (PubMed ID: 9665198)
1. Mutational analysis of the tumor suppressor Smad2 in acute lymphoid and myeloid leukemia.
Wieser R; Gruber B; Rieder H; Fonatsch C
Leukemia; 1998 Jul; 12(7):1114-8. PubMed ID: 9665198
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Smad2 gene in hematological malignancies.
Ikezoe T; Takeuchi S; Kamioka M; Daibata M; Kubonishi I; Taguchi H; Miyoshi I
Leukemia; 1998 Jan; 12(1):94-5. PubMed ID: 9436926
[TBL] [Abstract][Full Text] [Related]
3. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
4. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutational analysis of the MADR2/Smad2 gene in human prostate cancer.
Latil A; Pesche S; Valéri A; Fournier G; Cussenot O; Lidereau R
Prostate; 1999 Sep; 40(4):225-31. PubMed ID: 10420150
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
7. MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma.
Maesawa C; Tamura G; Nishizuka S; Iwaya T; Ogasawara S; Ishida K; Sakata K; Sato N; Ikeda K; Kimura Y; Saito K; Satodate R
Jpn J Cancer Res; 1997 Apr; 88(4):340-3. PubMed ID: 9197523
[TBL] [Abstract][Full Text] [Related]
8. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
10. C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.
Koike M; Chumakov AM; Takeuchi S; Tasaka T; Yang R; Nakamaki T; Tsuruoka N; Koeffler HP
Leuk Res; 1997 Sep; 21(9):833-9. PubMed ID: 9393598
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
[TBL] [Abstract][Full Text] [Related]
12. No mutations of the Smad2 gene in human sporadic gastric carcinomas.
Shitara Y; Yokozaki H; Yasui W; Takenoshita S; Kuwano H; Nagamachi Y; Tahara E
Jpn J Clin Oncol; 1999 Jan; 29(1):3-7. PubMed ID: 10073143
[TBL] [Abstract][Full Text] [Related]
13. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia.
Montpetit A; Larose J; Boily G; Langlois S; Trudel N; Sinnett D
Leukemia; 2004 Sep; 18(9):1499-504. PubMed ID: 15284860
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
16. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
17. INI-1, a partner gene of ALL-1, is highly conserved in human acute leukemia.
Mimori K; Inoue H; Ishii H; Mori M
Oncol Rep; 2003; 10(3):551-3. PubMed ID: 12684622
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
Maliekal TT; Antony ML; Nair A; Paulmurugan R; Karunagaran D
Oncogene; 2003 Jul; 22(31):4889-97. PubMed ID: 12894231
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma.
Osawa H; Shitara Y; Shoji H; Mogi A; Kuwano H; Hagiwara K; Takenoshita S
Int J Oncol; 2000 Oct; 17(4):723-8. PubMed ID: 10995883
[TBL] [Abstract][Full Text] [Related]
20. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
